NASDAQ: NMRA Lawsuit Alert: Investors with substantial Losses from shares of Neumora Therapeutics, Inc. (NASDAQ: NMRA) should contact the Shareholders Foundation

On February 06 2025, an investor in NASDAQ: NMRA shares filed a lawsuit against Neumora Therapeutics, Inc. over alleged securities laws violations. The plaintiff claimed that the Offering Documents that were filed in connection with Neumora's September 2023 initial public offering contained false and/or misleading statements and/or failed to disclose that in order for Neumora to justify conducting its Phase Three Program, Neumora was forced to amend BlackThorn's original Phase Two Trial inclusion criteria to include a patient population with moderate to severe MDD to show that Navacaprant offered a statistically significant improvement in treating MDD, that and to that same end, the Company also added a prespecified analysis to the Phase Two statistical analysis plan, focusing on patients suffering from moderate to severe MDD, and that the Phase Two Trials lacked adequate data, particularly in regards to the patient population size and the ratio of male to female patients within the patient population, to be able to accurately predict the results of the KOASTAL-1 study..

Those who purchased shares of Neumora Therapeutics, Inc. (NASDAQ: NMRA) should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc. 
Michael Daniels 
+1 (858) 779-1554 
mail@shareholdersfoundation.com 
3111 Camino Del Rio North 
Suite 423 
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nasdaq-nmra-lawsuit-alert-investors-with-substantial-losses-from-shares-of-neumora-therapeutics-inc-nasdaq-nmra-should-contact-the-shareholders-foundation-302398243.html

SOURCE Shareholders Foundation, Inc.